NCT05558904
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- Yesenia Calzada Los Angeles, California, United States
Clinical trial condition
Lung Adenocarcinoma
Explore clinical trials studying Lung Adenocarcinoma. Study availability and eligibility vary by location and protocol.
76 public trials
33 recruiting studies
Lung Adenocarcinoma trial results
NCT05517811
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Biliary Cancer, +34 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
Recruiting
Lymph Node Pathologic Grading Strategy
NCT06745830
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT05925764
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Artificial Intelligence, +11 more
- Locations
-
- Affiliated Hospital of Zunyi Medical University Zunyi, Guizhou, China
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
- Ningbo HwaMei Hospital Ningbo, Zhejiang, China
Recruiting
Segmentectomy for Solid-dominant Lung Cancer
NCT06634966
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT05717803
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK
NCT05266846
- Conditions
- ALK Gene Mutation, Adenocarcinoma, Adenocarcinoma of Lung, +10 more
- Locations
-
- Hunan Cancer Hospital Changsha, Hunan, China
Recruiting
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
- Locations
-
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
NCT06031181
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
- Locations
-
- Fudan University Cancer Center Shanghai, Shanghai Municipality, China
Recruiting
Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic
NCT06056115
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
- Locations
-
- The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital) Shijiazhuang, Hebei, China